Used for
Myelogenous chronic bcr-abl positive leukemia
5 medications the National Library of Medicine records as treating myelogenous chronic bcr-abl positive leukemia, and that we can price. Open one to see what it costs without insurance.
Listed alphabetically, not by preference. Which of these suits anyone is a question for a prescriber; what they cost is the question we can answer.
- BosutinibKinase Inhibitor$16,110.00Cost Plus Drugs
- Hydroxyurea · 4 strengths and formsAntimetabolite$13.23Cost Plus Drugs
Cheapest option we hold for the usual fill, fees included, checked November 5, 2026. Open a medicine for every option and the date on each one.